Cargando…

Two cases of Alzheimer’s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil

Rivastigmine, galantamine, and memantine, in addition to donepezil, which has been on the market over 10 years, have been available for the treatment of Alzheimer’s disease (AD) since 2011 in Japan, leading a new stage in the medical treatment of AD. We studied two AD patients showing sudden deterio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Takemi, Takamatsu, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534308/
https://www.ncbi.nlm.nih.gov/pubmed/23293526
http://dx.doi.org/10.2147/NDT.S37688

Ejemplares similares